Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.
By D. Schaer, P. Buehler, A. Alayash, J. Belcher, G. Vercellotti. Blood, 2013
727 citations recorded by the source corpus.
Subfields: Cell Biology, Molecular Biology, Pediatrics, Perinatology and Child Health
View Paper: https://www.semanticscholar.org/paper/a53718b74b3298b35cb7ea2ea775b944a7800826
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Everts
- J. Belcher
- K. Onishi
- Chunsheng Chen
- P. Jayaram
- Ann Smith
- R. Hebbel
- K. Nath
Citations in the corpus
- Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. (2014, background): “Specifically, this study examined the hypothesis that heme, released from plasma Hb during hemolysis, is an extracellular cell-signaling molecule and a causal factor in the development of vascular inflammation and vaso-occlusion in SCD.”
- Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020 (2020, background): “As a consequence, the RBC cell membrane disintegrates and releases toxic hemoglobin (Hb), measured as plasma-free hemoglobin (PFH), hemin, and iron [75].”